• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconNovavax

Novavax

Robert F. Kennedy Jr. looks forward, while Donald Trump looks back at him.
Finance
Moderna and Novavax shares plunge after key FDA official steps down, citing discord with RFK Jr. who he says ‘wishes subservient confirmation of his misinformation and lies’
By Sasha RogelbergMarch 31, 2025
About 47% of U.S. adults aged 50 and older said they were very or somewhat unlikely to get the new 2024–25 COVID-19 vaccine, according the University of Michigan’s National Poll on Healthy Aging.
Health
COVID sickens older adults most severely, but less than half say they’ll get the new vaccine
By Lindsey LeakeSeptember 30, 2024
Citing skyrocketing COVID spread, the FDA announced in late August that it had approved Pfizer’s Comirnaty and Moderna’s Spikevax vaccines early.
Health
New COVID vaccines are here. What to know about latest shots in wake of nation’s biggest summer surge
By Lindsey LeakeAugust 29, 2024
A Novavax scientist works in a lab
Health
A COVID-vaccine maker received $1.6 billion in Operation Warp Speed funding. It’s administered just 7,300 shots in the U.S.
By Nicholas GordonAugust 9, 2022
Novavax-lab-vaccine-covid
Health
A ‘breadth of protection’: Novavax’s newly approved COVID vaccine arms the U.S. with a new weapon against Omicron BA.5 subvariant
By Grady McGregorJuly 14, 2022
Novovax COVID-19 vaccine
Health
Novavax’s COVID-19 vaccine could finally be approved in the U.S. this month
By Lauran Neergaard and The Associated PressJune 2, 2022
Japan's Prime Minister Fumio Kishida recevies a booster shot, in March 2022
Health
Novavax stock continues its monthslong slide even after COVID vaccine earns approval in another country
By Eamon BarrettApril 19, 2022
Indian students wait in line for a COVID vaccine
Health
India is the first country to approve the Novavax vaccine for teens, as the world readies for another COVID wave
By Nicholas GordonMarch 23, 2022
The weird case of Novavax’s falling stock price: The vaccine that might be big news for the vax hesitant
Health
The weird case of Novavax’s falling stock price: The vaccine that might be big news for the vax hesitant
By Andrew MarquardtMarch 15, 2022
Singapore is the latest country to approve Novavax’s COVID vaccine while the U.S. reviews application
Health
Singapore is the latest country to approve Novavax’s COVID vaccine while the U.S. reviews application
By Grady McGregorFebruary 14, 2022
Sign outside Novavax Inc. headquarters in Gaithersburg, Md.
Health
Novavax’s newest approvals position it as an mRNA ‘alternative’ that health officials say may convince vaccine skeptics
By Grady McGregorFebruary 4, 2022
Meet the Novastans: How Novavax vaccine’s cultlike following could alter the course of COVID
Health
Meet the Novastans: How Novavax vaccine’s cultlike following could alter the course of COVID
By Grady McGregorJanuary 27, 2022
Novavax’s COVID-19 vaccine gains momentum with Australia approval
Health
Novavax’s COVID-19 vaccine gains momentum with Australia approval
By Grady McGregorJanuary 19, 2022
Novavax CEO Stanley Erck
Health
When will Novavax’s vaccine be ready? CEO Stanley Erck says 10 countries may approve its COVID shot in next 90 days
By Grady McGregorJanuary 11, 2022
Photo illustration of a syringe jabbing a stock chart that shows shares rising and then falling
Finance
Omicron is upping booster jab demand. So why are COVID vaccine makers’ shares tanking?
By Jeremy KahnDecember 29, 2021
1
  • 1
  • 2
2
Most Popular
Law
Egg companies made $1.22 billion in profit off a $6 carton — now they’re buying their way out of a price-fixing case with 53 million donated eggsplaceholder alt text
By Wyatte Grantham-Philips and The Associated PressJuly 2, 2026
AI
Meet the Zillennials: The luckiest micro-generation in the workforce, born between 1993 and 1998placeholder alt text
By Nick LichtenbergJuly 3, 2026
Economy
Economists have found an answer to slowing cognitive decline: Avoid retiring early, study findsplaceholder alt text
By Sasha RogelbergJuly 2, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.